Menu
No results found.
Weekly Share Price & Valuation Overview
Dolby Laboratories, Inc.
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions primarily for application in the television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. Its audio technologies also include DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a next-generation digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a next generation SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Double-digit profit margin (≥10%) supports robust bottom-line economics.
- Earnings growth ≥10% supports improving profitability trajectory.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
- Market Cap Total equity value of the company (share price × shares outstanding).
- USD 6.98B
- Enterprise Value Operating value: market cap + total debt − cash.
- USD 6.33B
- Total Revenue (TTM) Estimated Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- USD 860.13M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- USD 1.19B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- USD 376.41M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- USD 14.06
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 2.71
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 1.81%
- Shares Outstanding
- 61.18M
- Float Shares
- 60.41M
- Implied Shares Outstanding
- 96.32M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
14.92%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
43.76%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
138.62%
- Profit Margin (TTM) Solid Net income ÷ revenue over the last twelve months (reconciled when possible).
-
19.62%
- ROA Return on assets: net income ÷ total assets.
-
5.86%
- ROE Return on equity: net income ÷ shareholder equity.
-
10.50%
- Revenue Growth Year-over-year revenue growth.
-
9.30%
- Earnings Growth (YoY) Strong Year-over-year earnings growth.
-
20.00%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
19.80%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 3.09
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 1.50
- Total Cash Cash and equivalents.
- USD 699.33M
- Total Debt Short + long-term interest-bearing debt.
- USD 39.11M
- Net Debt Net Cash Total debt − cash (negative = net cash).
- USD -660.22M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 0.10
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- USD 465.54M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- USD 375.60M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
54.12%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
43.67%
- Cash Conversion (OpCF/EBITDA)
- 1.24
- Total Revenue (TTM) estimated from Revenue per Share × Shares due to feed inconsistency.
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.